Clinical and regulated data infrastructure

Clinical data becomes useful when it remains traceable, reusable, and reviewable.

Regulated biomedical work depends on secure data flow, reproducible analysis, traceable decisions, clear documentation, and outputs that support review, audit, and reuse. My work connects clinical genomics, EHR-linked data, multi-omics, governance, secure compute, and structured reporting.

What this work resolves

Traceable evidence

Clinical data workflows need clear links between source data, processing, analysis, interpretation, and final output.

Secure reuse

Biomedical data becomes more valuable when it can be reused safely across research, clinical, governance, and translational contexts.

Regulated reporting

Reports, databases, pipelines, and documentation need enough structure to support review, quality control, and later audit.

Cross-functional delivery

Clinical infrastructure has to satisfy clinicians, data scientists, bioinformaticians, governance teams, software teams, and decision-makers at the same time.

Evidence at a glance

>1,000 patients in secure clinical genomic, multi-omic, and EHR-linked workflows
>100 TB biomedical data managed through traceable analytical infrastructure
>10 hospitals connected through multi-institutional clinical research programmes
>CHF 6M in combined national funding programmes

Portfolio samples

Qualifying variant database. The open standard for variant interpretation, with trusted QV sets to enhance clarity and reproducibility in genetics.

PanelAppRex AI. Harmonised disease-gene panels from structured clinical and genetic queries. For humans and for machines.

Methods, standards, and systems

Clinical data workflows

Patient-level data, EHR-linked workflows, phenotype-linked molecular data, cohort definition, missingness, data quality, and longitudinal data structures.

Secure infrastructure

High-performance computing, Unix, Linux, encrypted storage, controlled file transfer, AWS, Azure, Docker, Singularity or Apptainer, and structured data environments.

Regulated delivery

Good Clinical Practice, GLP-aware laboratory delivery, ICH-aligned documentation discipline, audit-ready workflows, traceability, version control, and quality records.

Analytical reproducibility

R, Python, Git, workflow automation, reproducible reports, machine-readable outputs, versioned pipelines, QC checks, and structured analytical documentation.

Biomedical systems

SQL, PostgreSQL, APIs, HTML reporting, Next.js, React, TypeScript, Supabase, authenticated systems, and user-facing scientific platforms.

Stakeholder translation

Clinical research, data governance, genomics, bioinformatics, data science, neonatology, intensive care, scientific leadership, and external partner coordination.

Selected technologies

Selected publications

ORCID record: ORCID iD 0000-0001-8496-3725

Application of qualifying variants for genomic analysis. Bioinformatics, 42(2), btaf676, 2026.

Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. Blood, 136(9), 1055-1066, 2020.

Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder. eLife, 10(), , 2021.

A case of adult-onset Still's disease caused by a novel splicing mutation in TNFAIP3 successfully treated with tocilizumab. Frontiers in Immunology, 9(), , 2018.

Relevant experience

2023 to present · Universitäts-Kinderspital Zürich

Secure clinical genomics and data infrastructure

Designed analytical workflows and clinical research databases for paediatric critical care, rare disease, genomics, multi-omics, and EHR-linked research.

Approximately 1,000 children, more than 100 TB of biomedical data, three hospitals, SwissPedHealth National Data Stream, Swiss Pediatric Sepsis Study, governance-facing workflows.

2018 to 2023 · EPFL Global Health Institute

Translational cohort systems and analytical delivery

Built reproducible computational workflows for infectious, inflammatory, and translational studies across Swiss and international collaborators.

Cohorts up to 5,000 participants, multidisciplinary teams across EPFL, ETH Zürich, Swiss university hospitals, Swiss TPH, and international partners.

2014 to 2015 · ACM Global Laboratories

Regulated laboratory and clinical trial delivery

Delivered biomarker and assay workflows in a regulated bioanalytical laboratory serving global clinical trial programmes.

Quality-controlled assay delivery, documentation discipline, biomarker workflows, regulated laboratory operations, development-stage decision support.

Working fit

Clinical and regulated data teams need evidence systems that can be inspected, reused, and defended. The useful output is not only analysis, but a reliable chain from source data to structured decision support.